Valuation: Olympus Corporation

Market Cap 1,927B 12.23B 10.62B 9.9B 9.1B 17.2B 1,163B 17.39B 117B 45.63B 581B 45.92B 44.92B P/E 2027 *
19.9x
P/E 2028 * 16.6x
Enterprise Value 1,993B 12.65B 10.98B 10.24B 9.41B 17.79B 1,203B 17.98B 121B 47.19B 601B 47.49B 46.45B EV / Sales 2027 *
1.87x
EV / Sales 2028 * 1.79x
Free-Float
94.53%
Yield 2027 *
1.7%
Yield 2028 * 1.78%
1 day-0.83%
1 week-3.41%
Current month-1.15%
1 month+1.98%
3 months+17.24%
6 months-3.23%
Current year-9.35%
1 week 1,761
Extreme 1761
1,887.5
1 month 1,703
Extreme 1703
1,887.5
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-3.41%+0.17%-22.31% 12.23B
-1.62%-2.02%+21.04%+2.94% 209B
-1.38%-2.15%-1.36%-23.54% 137B
-1.90%+1.79%-23.81%+19.06% 130B
+1.36%+6.58%-54.03%-3.21% 71.14B
+0.88%+7.07%+11.87%+12.63% 51.59B
-0.28%+8.57%-15.66%-20.88% 49.99B
-0.43%-0.95%+21.21%+10.21% 39.31B
+5.69%+3.17%+38.69%+36.63% 38.89B
+0.76%+9.59%-0.54%-7.43% 31.74B
Average +0.43%+2.81%-0.24%+0.41% 77.07B
Weighted average by Cap. -0.01%+1.45%-0.75%+0.73%

Financials

2027 *2028 *
Net sales 1,068B 6.78B 5.89B 5.49B 5.04B 9.53B 645B 9.64B 64.69B 25.29B 322B 25.45B 24.89B 1,108B 7.03B 6.11B 5.69B 5.23B 9.89B 669B 10B 67.12B 26.24B 334B 26.41B 25.83B
Net income 98.69B 626M 544M 507M 466M 881M 59.58B 891M 5.98B 2.34B 29.78B 2.35B 2.3B 117B 744M 646M 602M 553M 1.05B 70.74B 1.06B 7.1B 2.77B 35.36B 2.79B 2.73B
Net Debt 65.76B 417M 362M 338M 310M 587M 39.7B 593M 3.98B 1.56B 19.85B 1.57B 1.53B 56.53B 359M 312M 290M 267M 505M 34.13B 510M 3.42B 1.34B 17.06B 1.35B 1.32B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-08-05 ¥1,807.00 -0.39% 1,434,200
26-08-04 ¥1,814.00 -0.27% 2,845,400
26-08-03 ¥1,819.00 -0.05% 4,210,500
26-07-31 ¥1,820.00 -2.02% 5,361,000
26-07-30 ¥1,857.50 -0.27% 3,701,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,814.00JPY
Average target price
1,916.92JPY
Spread / Average Target
+5.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock